IL11 enhances tumor cell proliferation, migration, EMT, and invasion of NSCLC cells via activation of STAT3, while depletion of IL11 significantly impairs the growth of NSCLC xenografts in mice and improves survival [182]. Here, STAT3 is linked to non-small cell lung carcinoma.